Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xenogan and Chlorella with metformin and vitamin E in non-alcoholic fatty liver disease
IRCT20221018056221N1Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jan 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of chlorella vulgaris, metformin and vitamin e in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Kermanshah University of Medical Sciences. Started Jan 2023; status: completed.
02
Drugs
chlorella vulgarismetforminvitamin e
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on IRCT20221018056221N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221018056221N1.